Global Pregabalin Market 2022-2026

PUBLISHED: September 5, 2022

PAGES: 120 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Technavio has been monitoring the pregabalin market and it is poised to grow by $153.03 mn during 2022-2026, accelerating at a CAGR of 3.74% during the forecast period. Our report on the pregabalin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the presence of a large patient pool related to neuropathic pain, an increasing geriatric population, and rising applications of pregabalin in various diseases.

The pregabalin market analysis includes the application segment and geographic landscape.

Technavio's pregabalin market is segmented as below:

By Application

Neuropathic pain
Epilepsy
Anxiety disorders
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing focus on emerging economies as one of the prime reasons driving the pregabalin market growth during the next few years. Also, increasing incidence of diabetes and HIV and rising healthcare expenditure will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the pregabalin market covers the following areas:

Pregabalin market sizing
Pregabalin market forecast
Pregabalin market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pregabalin market vendors that include Biomax Biotechnics Pvt. Ltd., Camber Pharmaceuticals Inc., Cipla Ltd., Dr. Kumars Pharmaceuticals, Genesis Biotec Inc., H. L. Healthcare Pvt. Ltd., Lupin Ltd, Medley Pharmaceuticals Ltd., MK Medicine, MSN Laboratories, Neuracle Lifesciences Pvt. Ltd., Novartis AG, Pfizer Inc., Phoenix Biologicals Pvt. Ltd., Sun Pharmaceutical Industries Ltd, Swastik Life Sciences, Torrent Pharmaceuticals Ltd., and Vibcare Pharma Pvt. Ltd. Also, the pregabalin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74278

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

5.1 Market segments
Exhibit 24: Chart on Application - Market share 2021-2026 (%)
Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
5.2 Comparison by Application
Exhibit 26: Chart on Comparison by Application
Exhibit 27: Data Table on Comparison by Application
5.3 Neuropathic pain - Market size and forecast 2021-2026
Exhibit 28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)
5.4 Epilepsy - Market size and forecast 2021-2026
Exhibit 32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)
5.5 Anxiety disorders - Market size and forecast 2021-2026
Exhibit 36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Application
Exhibit 44: Market opportunity by Application ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 Canada - Market size and forecast 2021-2026
Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Republic of Korea - Market size and forecast 2021-2026
Exhibit 86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibit 88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibit 89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 90: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 91: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 93: Overview on factors of disruption
9.4 Industry risks
Exhibit 94: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 95: Vendors covered
10.2 Market positioning of vendors
Exhibit 96: Matrix on vendor position and classification
10.3 Biomax Biotechnics Pvt. Ltd.
Exhibit 97: Biomax Biotechnics Pvt. Ltd. - Overview
Exhibit 98: Biomax Biotechnics Pvt. Ltd. - Product / Service
Exhibit 99: Biomax Biotechnics Pvt. Ltd. - Key offerings
10.4 Camber Pharmaceuticals Inc.
Exhibit 100: Camber Pharmaceuticals Inc. - Overview
Exhibit 101: Camber Pharmaceuticals Inc. - Product / Service
Exhibit 102: Camber Pharmaceuticals Inc. - Key offerings
10.5 Cipla Ltd.
Exhibit 103: Cipla Ltd. - Overview
Exhibit 104: Cipla Ltd. - Business segments
Exhibit 105: Cipla Ltd. - Key news
Exhibit 106: Cipla Ltd. - Key offerings
Exhibit 107: Cipla Ltd. - Segment focus
10.6 Genesis Biotec Inc.
Exhibit 108: Genesis Biotec Inc. - Overview
Exhibit 109: Genesis Biotec Inc. - Product / Service
Exhibit 110: Genesis Biotec Inc. - Key offerings
10.7 Lupin Ltd
Exhibit 111: Lupin Ltd - Overview
Exhibit 112: Lupin Ltd - Product / Service
Exhibit 113: Lupin Ltd - Key news
Exhibit 114: Lupin Ltd - Key offerings
10.8 Medley Pharmaceuticals Ltd.
Exhibit 115: Medley Pharmaceuticals Ltd. - Overview
Exhibit 116: Medley Pharmaceuticals Ltd. - Product / Service
Exhibit 117: Medley Pharmaceuticals Ltd. - Key offerings
10.9 MK Medicine
Exhibit 118: MK Medicine - Overview
Exhibit 119: MK Medicine - Product / Service
Exhibit 120: MK Medicine - Key offerings
10.10 Novartis AG
Exhibit 121: Novartis AG - Overview
Exhibit 122: Novartis AG - Business segments
Exhibit 123: Novartis AG - Key offerings
Exhibit 124: Novartis AG - Segment focus
10.11 Pfizer Inc.
Exhibit 125: Pfizer Inc. - Overview
Exhibit 126: Pfizer Inc. - Product / Service
Exhibit 127: Pfizer Inc. - Key news
Exhibit 128: Pfizer Inc. - Key offerings
10.12 Torrent Pharmaceuticals Ltd.
Exhibit 129: Torrent Pharmaceuticals Ltd. - Overview
Exhibit 130: Torrent Pharmaceuticals Ltd. - Business segments
Exhibit 131: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibit 132: Torrent Pharmaceuticals Ltd. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 133: Inclusions checklist
Exhibit 134: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 135: Currency conversion rates for US$
11.4 Research methodology
Exhibit 136: Research methodology
Exhibit 137: Validation techniques employed for market sizing
Exhibit 138: Information sources
11.5 List of abbreviations
Exhibit 139: List of abbreviations
- Population
- pressure
- in incidence rate

Product Code: IRTNTR74278

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Application ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Biomax Biotechnics Pvt. Ltd. - Overview
Exhibits98: Biomax Biotechnics Pvt. Ltd. - Product / Service
Exhibits99: Biomax Biotechnics Pvt. Ltd. - Key offerings
Exhibits100: Camber Pharmaceuticals Inc. - Overview
Exhibits101: Camber Pharmaceuticals Inc. - Product / Service
Exhibits102: Camber Pharmaceuticals Inc. - Key offerings
Exhibits103: Cipla Ltd. - Overview
Exhibits104: Cipla Ltd. - Business segments
Exhibits105: Cipla Ltd. - Key news
Exhibits106: Cipla Ltd. - Key offerings
Exhibits107: Cipla Ltd. - Segment focus
Exhibits108: Genesis Biotec Inc. - Overview
Exhibits109: Genesis Biotec Inc. - Product / Service
Exhibits110: Genesis Biotec Inc. - Key offerings
Exhibits111: Lupin Ltd - Overview
Exhibits112: Lupin Ltd - Product / Service
Exhibits113: Lupin Ltd - Key news
Exhibits114: Lupin Ltd - Key offerings
Exhibits115: Medley Pharmaceuticals Ltd. - Overview
Exhibits116: Medley Pharmaceuticals Ltd. - Product / Service
Exhibits117: Medley Pharmaceuticals Ltd. - Key offerings
Exhibits118: MK Medicine - Overview
Exhibits119: MK Medicine - Product / Service
Exhibits120: MK Medicine - Key offerings
Exhibits121: Novartis AG - Overview
Exhibits122: Novartis AG - Business segments
Exhibits123: Novartis AG - Key offerings
Exhibits124: Novartis AG - Segment focus
Exhibits125: Pfizer Inc. - Overview
Exhibits126: Pfizer Inc. - Product / Service
Exhibits127: Pfizer Inc. - Key news
Exhibits128: Pfizer Inc. - Key offerings
Exhibits129: Torrent Pharmaceuticals Ltd. - Overview
Exhibits130: Torrent Pharmaceuticals Ltd. - Business segments
Exhibits131: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibits132: Torrent Pharmaceuticals Ltd. - Segment focus
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations